Cassady Schiller Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$59.4K Buy
228
+23
+11% +$6.82K 0.02% 194
2024
Q3
$66.1K Hold
205
0.02% 182
2024
Q2
$64.1K Sell
205
-18
-8% -$5.29K 0.03% 177
2024
Q1
$63.4K Buy
223
+4
+2% +$1.17K 0.03% 192
2023
Q4
$63.1K Hold
219
0.03% 184
2023
Q3
$58.9K Buy
219
+18
+9% +$4.49K 0.03% 181
2023
Q2
$44.6K Sell
201
-100
-33% -$23.2K 0.02% 209
2023
Q1
$72.8K Sell
301
-109
-27% -$26.8K 0.03% 167
2022
Q4
$108K Buy
+410
New +$110K 0.07% 130
2022
Q1
Sell
-409
Closed -$92K 133
2021
Q4
$92K Buy
+409
New +$86.3K 0.06% 139

Other funds holding AMGN

Cassady Schiller Wealth Management's AMGN Position: Q4 2024 in Review

Cassady Schiller Wealth Management increased its Amgen (AMGN) stake by 11% in Q4 2024, buying an estimated $6.82K and bringing the position to 228 shares worth $59.4K. The position accounts for 0.02% of the portfolio, ranked #194.

Cassady Schiller Wealth Management first reported a position in AMGN in Q4 2021 and has held it in 10 quarters since. The position peaked at $108K in Q4 2022. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

  • Cassady Schiller Wealth Management held 228 shares of Amgen worth $59.4K as of Q4 2024.
  • Cassady Schiller Wealth Management bought 23 Amgen shares in Q4 2024, an estimated $6.82K.
  • Amgen made up 0.02% of Cassady Schiller Wealth Management's portfolio in Q4 2024, its #194 holding.
  • Cassady Schiller Wealth Management first reported a position in Amgen in Q4 2021 and has held it in 10 quarters since.
  • Cassady Schiller Wealth Management's Amgen position peaked at $108K in Q4 2022.
  • 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on Cassady Schiller Wealth Management's 13F filing for Q4 2024, filed 10 Feb 2025.